Production/Testing of a MVA Vaccine
$243,579N01FY2011AINIH
Sanofi Pasteur Biologics, Llc, Cambridge MA
Investigators
Abstract
The purpose of this contract is to support the advanced development and manufacture of a Modified Vaccinia Ankara (MVA) vaccine for smallpox.
View original record on NIH RePORTER →